PLCG2 promotes hepatocyte proliferation in vitro via NF-κB and ERK pathway by targeting bcl2, myc and ccnd1

References

• Katan M. The control of inositol lipid hydrolysis. Cancer Surv. 1995;27:199–211.
   Google Scholar
• Cockcroft S, Thomas GM. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J. 1992;288(1):1.
   PubMed Web of Science ®Google Scholar
• Lee SB, Rhee SG. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes. Curr Opin Cell Biol. 1995;7(2):183–189.
   PubMed Web of Science ®Google Scholar
• Rhee SG, Bae YS. Regulation of phosphoinositide-specific phospholipase C isozymes. J Biol Chem. 1997;272(24):15045–15048.
   PubMed Web of Science ®Google Scholar
• Williams RL, Katan M. Structural views of phosphoinositide-specific phospholipase C: signalling the way ahead. Structure. 1996;4(12):1387–1394.
   PubMed Web of Science ®Google Scholar
• Heinz DW, Essen LO, Williams RL. Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositide-specific phospholipases C. J Mol Biol. 1998;275(4):635–650.
   PubMed Web of Science ®Google Scholar
• Munnik T, Irvine RF, Musgrave A. Phospholipid signalling in plants. Biochimica et Biophysica Acta (BBA)-Lip Lip Metabol. 1998;1389(3):222–272.
   PubMed Web of Science ®Google Scholar
• Shortridge RD, McKay RR. Invertebrate phosphatidylinositol-specific phospholipases C and their role in cell signaling. Invert Neurosci. 1995;1(3):199–206.
   PubMed Web of Science ®Google Scholar
• van Haastert PJ, van Dijken P. Biochemistry and genetics of inositol phosphate metabolism in Dictyostelium. FEBS Lett. 1997;410(1):39–43.
   PubMed Web of Science ®Google Scholar
• Katan M. Families of phosphoinositide-speci¢c phospholipase C: structure and function. Biochimica et Biophysica Acta. 1998;1436(1–2):5–17.
   PubMed Web of Science ®Google Scholar
• Harborth J, Elbashir SM, Bechert K, et al. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J Cell Sci. 2001;114(24):4557–4565.
   PubMed Web of Science ®Google Scholar
• Lambolez B, Rossier J. Quantitative RT-PCR. Nat Biotechnol. 2000;18(1):5.
   PubMed Web of Science ®Google Scholar
• Kumar P, Nagarajan A, Uchil PD. Analysis of cell viability by the MTT assay. Cold Spring Harb Protoc. 2018;2018(6):pdb.prot095505.
   Google Scholar
• Harris L, Zalucki O, Piper M. BrdU/EdU dual labeling to determine the cell-cycle dynamics of defined cellular subpopulations. J Mol Hist. 2018;49(3):229–234.
   PubMed Web of Science ®Google Scholar
• Pozarowski P, Darzynkiewicz Z. Analysis of cell cycle by flow cytometry. Meth Mol Biol. 2004;281:301–311.
   PubMedGoogle Scholar
• Hnasko TS, Hnasko RM. The western blot. Meth Mol Biol. 2015;1318:87–96.
   PubMedGoogle Scholar
• Cavin LG, Romieu-Mourez R, Panta GR, et al. Inhibition of CK2 Activity by TGF-beta1 promotes IkappaB-alpha protein stabilization and apoptosis of immortalized hepatocytes. Hepatology. 2003;38(6):1540–1551.
   PubMed Web of Science ®Google Scholar
• Iimuro Y, Nishiura T, Hellerbrand C, et al. NFkappaB prevents apoptosis and liver dysfunction during liver regeneration. J Clin Invest. 1998;101(4):802.
   PubMed Web of Science ®Google Scholar
• Chaisson ML, Brooling JT, Ladiges W, et al. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J Clin Invest. 2002;110(2):193–202.
   PubMed Web of Science ®Google Scholar
• Iimuro Y, Fujimoto J. TLRs, NF-κB, JNK, and liver regeneration. Gastroenterol Res Pract. 2010;2010:1–7.
   Web of Science ®Google Scholar
• Yang LQ, Fang DC, Wang RQ, et al. Effect of NF-kappaB, survivin, Bcl-2 and Caspase3 on apoptosis of gastric cancer cells induced by tumor necrosis factor related apoptosis inducing ligand. World J Gastroenterol. 2004;10(1):22–25.
   PubMed Web of Science ®Google Scholar
• Hsieh HL, Wang HH, Wu WB, et al. Transforming growth factor-b1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK-and JNK-NF-kB pathways. J Neuroinflammation. 2010;7(1):88.
   PubMed Web of Science ®Google Scholar
• Arsura M, Panta GR, Bilyeu JD, et al. Transient activation of NF-kappaB through a TAK1/IKK kinase pathway by TGF-beta1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene. 2003;22(3):412–425.
   PubMed Web of Science ®Google Scholar
• Tamatani M, Mitsuda N, Matsuzaki H, et al. A pathway of neuronal apoptosis induced by hypoxia/reoxygenation: roles of nuclear factor-kappaB and Bcl-2. J Neurochem. 2000;75(2):683–693.
   PubMed Web of Science ®Google Scholar
• Luqman S, Pezzuto JM. NFkappaB: a promising target for natural products in cancer chemoprevention. Phytother Res. 2010;24(7):949–963.
   PubMed Web of Science ®Google Scholar
• Yang GF, Deng CS, Xiong YY, et al. Expression of NFkappaB p65 and its target genes in gastric cancer and precancerous lesions. Zhonghua zhong liu za zhi [Chinese Journal of Oncology]. 2004;26(9):551–553.
   PubMedGoogle Scholar
• Karin M. Signal transduction from the cell surface to the nucleus through the phosphorylation of transcription factors. Curr Op Cell Biol. 1994;6(3):415–424.
   PubMed Web of Science ®Google Scholar
• Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49–139.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Op Cell Biol. 1997;9(2):180–186.
   PubMed Web of Science ®Google Scholar
• Jenkins AJ, Velarde V, Klein RL, et al. Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes. 2000;49(12):2160–2169.
   PubMed Web of Science ®Google Scholar
• Sundberg LJ, Galante LM, Bill HM, et al. An endogenous inhibitor of focal adhesion kinase blocks Rac1/JNK but not Ras/ERK-dependent signaling in vascular smooth muscle cells. J Biol Chem. 2003;278(32):29783–29791.
   PubMed Web of Science ®Google Scholar
• Velarde V, Jenkins AJ, Christopher J, et al. Activation of MAPK by modified low-density lipoproteins in vascular smooth muscle cells. J Appl Physiol. 2001;91(3):1412–1420.
   PubMed Web of Science ®Google Scholar
• Yang GY, Yao JS, Huey M, et al. Participation of PI3K and ERK1/2 pathways are required for human brain vascular smooth muscle cell migration. Neurochem Int. 2004;44(6):441–446.
   PubMed Web of Science ®Google Scholar
• Albanese C, Johnson J, Watanabe G, et al. Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem. 1995;270(40):23589–23597.
   PubMed Web of Science ®Google Scholar
• Liu YC, Chang HW, Lai YC, et al. Serum responsiveness of the rat PCNA promoter involves the proximal ATF and AP-1 sites. FEBS Lett. 1998;441(2):200–204.
   PubMed Web of Science ®Google Scholar
• Nelsen CJ, Rickheim DG, Timchenko NA, et al. Transient expression of cyclin D1 is sufficient to promote hepatocyte replication and liver growth in vivo. Cancer Res. 2001;61(23):8564–8568.
   PubMed Web of Science ®Google Scholar
• Rickheim DG, Nelsen CJ, Fassett JT, et al. Differential regulation of cyclins D1 and D3 in hepatocyte proliferation. Hepatology. 2002;36(1):30–38.
   PubMed Web of Science ®Google Scholar
• Kundu M, Guermah M, Roeder RG, et al. Interaction between cell cycle regulator, E2F-1, and NF-kappaB mediates repression of HIV-1 gene transcription. J Biol Chem. 1997;272(47):29468–29474.
   PubMed Web of Science ®Google Scholar
• Siebenlist U, Franzoso G, Brown K. Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol. 1994;10:405–455.
   PubMedGoogle Scholar
• Herber B, Truss M, Beato M, et al. Inducible regulatory elements in the human cyclin D1 promoter. Oncogene. 1994;9(4):1295–1304.
   PubMed Web of Science ®Google Scholar
• Watanabe G, Albanese C, Lee RJ, et al. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Sp1. Mol Cell Biol. 1998;18(6):3212–3222.
   PubMed Web of Science ®Google Scholar
• Lukas J, Bartkova J, Bartek J. Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint. Mol Cell Biol. 1996;16(12):6917.
   PubMed Web of Science ®Google Scholar
• Sherr CJ. Cancer cell cycles. Science. 1996;274(5293):1672–1677.
   PubMed Web of Science ®Google Scholar
• Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81(3):323–330.
   PubMed Web of Science ®Google Scholar